Scientific publications

Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK

Pennington B (1), Akehurst R (2), Wasan H (3), Sangro B (4), Kennedy AS (5), Sennfält K (6), Bester L (7).
(1a) BresMed , Sheffield , UK.
(2b) University of Sheffield , Sheffield , UK.
(3c) Medical Oncology, Hammersmith Hospital, Imperial NHS Trust , London , UK.
(4d) Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain; and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD) , Pamplona , Spain.
(5e) Radiation Oncology, Sarah Cannon Research Institute , Nashville , TN , USA.
(6f) Sirtex Medical Limited , North Sydney , NSW , Australia.
(7g) Interventional Radiology, University of New South Wales, St. Vincent's Hospital , Darlinghurst , NSW , Australia. 

Magazine: Journal of Medical Economics

Date: Jun 9, 2015

Hepatology

OBJECTIVE:
Selective internal radiation therapy (SIRT) using SIR-Spheres(®) (90)Y-labeled resin microspheres has been shown to be a well-tolerated, effective treatment in patients with inoperable liver-dominant chemotherapy-refractory metastatic colorectal cancer (mCRC). This study estimated the cost-effectiveness of (90)Y-resin microspheres compared to best supportive care (BSC) from a UK perspective.

METHODS:
Survival data from a comparative retrospective cohort study was analyzed and used in a state-transition cost-effectiveness model, using quality-adjusted life years (QALYs) gained as the measure of effectiveness. The model incorporated costs for the SIRT procedure, monitoring, further treatment, adverse events, and death. Utility values, reflecting patient quality-of-life, were taken from a published source.

RESULTS:
SIRT using (90)Y-resin microspheres compared to BSC improved overall survival by a mean of 1.12 life years and resulted in a cost per QALY gained of £28,216. In sensitivity analysis, this varied between £25,015-£28,817.

CONCLUSION:
In an area of large unmet need, treatment with (90)Y-resin microspheres offers a clinically effective and cost-effective treatment option.

CITATION  J Med Econ. 2015;18(10):797-804. doi: 10.3111/13696998.2015.1047779. Epub 2015 Jun 9.

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra